Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Poonam J. Bajwa"'
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 297(1)
The thiazolidinedione (TZD) drugs rosiglitazone (Ro) and pioglitazone (Po) are PPARγ agonists in widespread clinical use as insulin-sensitizing agents in Type 2 diabetes. On the basis of recent evidence implicating PPARγ as a positive modulator of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b01e0ceb701c6d62292a99fb086e0323
https://pubmed.ncbi.nlm.nih.gov/19443733
https://pubmed.ncbi.nlm.nih.gov/19443733
Publikováno v:
The FASEB Journal. 22
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::989576f350478d76777f7643a3bca718
https://doi.org/10.1096/fasebj.22.1_supplement.934.19
https://doi.org/10.1096/fasebj.22.1_supplement.934.19
Autor:
Ligia Toro, Abderrahmane Alioua, Jimmy W. Lee, Daniel S. Straus, Christian Lytle, Poonam J. Bajwa
Publikováno v:
American journal of physiology. Gastrointestinal and liver physiology. 293(6)
Fibrates are peroxisome proliferator-activated receptor-α (PPARα) ligands in widespread clinical use to lower plasma triglyceride levels. We investigated the effect of fenofibrate and clofibrate on ion transport in mouse intestine and in human T84
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efda39c02bb7fc3937193a0bdd596a8b
https://pubmed.ncbi.nlm.nih.gov/17916649
https://pubmed.ncbi.nlm.nih.gov/17916649
Publikováno v:
The FASEB Journal. 21
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70439bd60e4e5a526408900d741d2778
https://doi.org/10.1096/fasebj.21.5.a546
https://doi.org/10.1096/fasebj.21.5.a546
Autor:
Charles O. Elson, Monica J. Carson, Jimmy W. Lee, Poonam J. Bajwa, Yingzi Cong, Daniel S. Straus, Christian Lytle, Daniel R. Jeske
Publikováno v:
Gastroenterology. 133(1)
Background & Aims: Interleukin-10 knockout (IL-10 −/− ) mice spontaneously develop colitis characterized by T-helper cell type 1–polarized inflammation. We tested the possible therapeutic activity of the peroxisome proliferator-activated recept
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec531046c4b0c8b7033139fad646b731
https://pubmed.ncbi.nlm.nih.gov/17631136
https://pubmed.ncbi.nlm.nih.gov/17631136